CN Patent

CN106336403A — 依帕列净的工业制备方法

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2017-01-18 · 9y expired

What this patent protects

本发明公开了依帕列净的工业制备方法。具体地，本发明涉及下式所示依帕列净即(1S)‑1,5‑脱水‑1‑(4‑氯‑3‑{4‑[(3S)‑四氢呋喃‑3‑基氧基]苄基}苯基)‑D‑葡萄糖醇的制备方法，且包含在该方法中所获得的中间体。本发明所提供的依帕列净生产工艺稳定，可重现性好，适合规模化生产。

USPTO Abstract

本发明公开了依帕列净的工业制备方法。具体地，本发明涉及下式所示依帕列净即(1S)‑1,5‑脱水‑1‑(4‑氯‑3‑{4‑[(3S)‑四氢呋喃‑3‑基氧基]苄基}苯基)‑D‑葡萄糖醇的制备方法，且包含在该方法中所获得的中间体。本发明所提供的依帕列净生产工艺稳定，可重现性好，适合规模化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106336403A
Jurisdiction
CN
Classification
—
Expires
2017-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.